PMC:7358770 / 35402-35638 JSONTXT

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T333","span":{"begin":22,"end":25},"obj":"Body_part"},{"id":"T334","span":{"begin":37,"end":42},"obj":"Body_part"},{"id":"T335","span":{"begin":96,"end":103},"obj":"Body_part"}],"attributes":[{"id":"A333","pred":"fma_id","subj":"T333","obj":"http://purl.org/sig/ont/fma/fma62873"},{"id":"A334","pred":"fma_id","subj":"T334","obj":"http://purl.org/sig/ont/fma/fma63083"},{"id":"A335","pred":"fma_id","subj":"T335","obj":"http://purl.org/sig/ont/fma/fma67257"}],"text":"he control group. The IgM content in serum increased after the second immunization in the BCV N protein-loaded CNP group. These findings indicate that CNP can be used as a novel adjuvant in veterinary vaccine field [130].\nIn addition, t"}

{"project":"LitCovid-PD-UBERON","denotations":[{"id":"T23","span":{"begin":37,"end":42},"obj":"Body_part"}],"attributes":[{"id":"A23","pred":"uberon_id","subj":"T23","obj":"http://purl.obolibrary.org/obo/UBERON_0001977"}],"text":"he control group. The IgM content in serum increased after the second immunization in the BCV N protein-loaded CNP group. These findings indicate that CNP can be used as a novel adjuvant in veterinary vaccine field [130].\nIn addition, t"}

{"project":"LitCovid-PubTator","denotations":[{"id":"1158","span":{"begin":90,"end":93},"obj":"Species"}],"attributes":[{"id":"A1158","pred":"tao:has_database_id","subj":"1158","obj":"Tax:11128"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"he control group. The IgM content in serum increased after the second immunization in the BCV N protein-loaded CNP group. These findings indicate that CNP can be used as a novel adjuvant in veterinary vaccine field [130].\nIn addition, t"}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T385","span":{"begin":170,"end":171},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T386","span":{"begin":209,"end":214},"obj":"http://purl.obolibrary.org/obo/UBERON_0007688"}],"text":"he control group. The IgM content in serum increased after the second immunization in the BCV N protein-loaded CNP group. These findings indicate that CNP can be used as a novel adjuvant in veterinary vaccine field [130].\nIn addition, t"}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T525","span":{"begin":11,"end":16},"obj":"Chemical"},{"id":"T526","span":{"begin":96,"end":103},"obj":"Chemical"},{"id":"T527","span":{"begin":111,"end":114},"obj":"Chemical"},{"id":"T528","span":{"begin":115,"end":120},"obj":"Chemical"},{"id":"T529","span":{"begin":151,"end":154},"obj":"Chemical"},{"id":"T530","span":{"begin":178,"end":186},"obj":"Chemical"}],"attributes":[{"id":"A525","pred":"chebi_id","subj":"T525","obj":"http://purl.obolibrary.org/obo/CHEBI_24433"},{"id":"A526","pred":"chebi_id","subj":"T526","obj":"http://purl.obolibrary.org/obo/CHEBI_36080"},{"id":"A527","pred":"chebi_id","subj":"T527","obj":"http://purl.obolibrary.org/obo/CHEBI_80235"},{"id":"A528","pred":"chebi_id","subj":"T528","obj":"http://purl.obolibrary.org/obo/CHEBI_24433"},{"id":"A529","pred":"chebi_id","subj":"T529","obj":"http://purl.obolibrary.org/obo/CHEBI_80235"},{"id":"A530","pred":"chebi_id","subj":"T530","obj":"http://purl.obolibrary.org/obo/CHEBI_60809"}],"text":"he control group. The IgM content in serum increased after the second immunization in the BCV N protein-loaded CNP group. These findings indicate that CNP can be used as a novel adjuvant in veterinary vaccine field [130].\nIn addition, t"}

{"project":"LitCovid-sentences","denotations":[{"id":"T218","span":{"begin":18,"end":121},"obj":"Sentence"},{"id":"T219","span":{"begin":122,"end":221},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"he control group. The IgM content in serum increased after the second immunization in the BCV N protein-loaded CNP group. These findings indicate that CNP can be used as a novel adjuvant in veterinary vaccine field [130].\nIn addition, t"}

{"project":"LitCovid-PMC-OGER-BB","denotations":[{"id":"T997","span":{"begin":22,"end":25},"obj":"GO:0071735"},{"id":"T998","span":{"begin":37,"end":42},"obj":"UBERON:0001977"},{"id":"T999","span":{"begin":94,"end":103},"obj":"PG_4"},{"id":"T1000","span":{"begin":178,"end":186},"obj":"CHEBI:60809;CHEBI:60809"},{"id":"T30064","span":{"begin":56,"end":67},"obj":"NCBITaxon:11118"},{"id":"T35628","span":{"begin":189,"end":197},"obj":"SP_9"},{"id":"T30531","span":{"begin":222,"end":232},"obj":"CHEBI:33543;CHEBI:33543"}],"text":"he control group. The IgM content in serum increased after the second immunization in the BCV N protein-loaded CNP group. These findings indicate that CNP can be used as a novel adjuvant in veterinary vaccine field [130].\nIn addition, t"}

{"project":"MyTest","denotations":[{"id":"1158","span":{"begin":90,"end":93},"obj":"Species"}],"attributes":[{"id":"A1158","pred":"tao:has_database_id","subj":"1158","obj":"Tax:11128"}],"namespaces":[{"prefix":"_base","uri":"https://www.uniprot.org/uniprot/testbase"},{"prefix":"UniProtKB","uri":"https://www.uniprot.org/uniprot/"},{"prefix":"uniprot","uri":"https://www.uniprot.org/uniprotkb/"}],"text":"he control group. The IgM content in serum increased after the second immunization in the BCV N protein-loaded CNP group. These findings indicate that CNP can be used as a novel adjuvant in veterinary vaccine field [130].\nIn addition, t"}